Publication:
Executive function in end-stage renal disease: Acute effects of hemodialysis and associations with clinical factors.

dc.contributor.authorSánchez-Fernández, María Del Mar
dc.contributor.authorReyes Del Paso, Gustavo A
dc.contributor.authorGil-Cunquero, José Manuel
dc.contributor.authorFernández-Serrano, María José
dc.date.accessioned2023-01-25T10:21:50Z
dc.date.available2023-01-25T10:21:50Z
dc.date.issued2018-09-04
dc.description.abstractThere is evidence of cognitive impairment in patients with end-stage renal disease in hemodialysis (ESRD-HD). However, few studies have exhaustively analyzed executive functions (EFs) in this population, especially considering the influence of a wide range of clinical variables. This study analyzes performance in different EF components in ESRD-HD patients compared to a group of healthy controls (HCs), in addition to the acute effects of HD and the associations of cognitive performance with clinical variables. EFs were evaluated pre- and post-HD in 43 ESRD-HD patients and 42 HCs, using a battery of tests designed to assess EF domains. Age, schooling, mood and blood pressure were statistically controlled. Associations between performance and clinical factors were computed by correlations and hierarchical multiple regression analyses. The performance of the ESRD-HD patients was significantly lower than that of HCs in all the EF domains except for planning. Group differences were marginally significant for reasoning. HD produced no acute changes in global performance, with improvements see only in inhibition and working memory. EF scores were positively associated with total number of months previously transplanted, body mass index (BMI), dry weight, and levels of hemoglobin, albumin, ferritin, calcium, phosphorus, sodium, urea, and creatinine. Global EF functioning was lower in ESRD-HD patients than in HCs. No major acute HD-related EF changes were detected. These findings underline the importance of an adequate nutritional status for maintaining executive functioning in ESRD-HD patients.
dc.identifier.doi10.1371/journal.pone.0203424
dc.identifier.essn1932-6203
dc.identifier.pmcPMC6122819
dc.identifier.pmid30180208
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122819/pdf
dc.identifier.unpaywallURLhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0203424&type=printable
dc.identifier.urihttp://hdl.handle.net/10668/12903
dc.issue.number9
dc.journal.titlePloS one
dc.journal.titleabbreviationPLoS One
dc.language.isoen
dc.organizationHospital Universitario de Jaén
dc.page.numbere0203424
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshAdult
dc.subject.meshCognitive Dysfunction
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshKidney Failure, Chronic
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshRenal Dialysis
dc.titleExecutive function in end-stage renal disease: Acute effects of hemodialysis and associations with clinical factors.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number13
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC6122819.pdf
Size:
2.07 MB
Format:
Adobe Portable Document Format